[hot spot] special collection of anticancer drugs: the price negotiation of imatinib in Henan Province has not been reached, and the whole group of flow standard (the bid winning situation of imatinib in all parts of the country is attached in the paper)

On January 15, the office of the Joint Conference on centralized bidding and procurement of Henan Medicine issued the notice on regulating the procurement and use of some anticancer drugs (hereinafter referred to as the notice) According to the notice, according to the implementation plan for special centralized purchase of anticancer drugs in public hospitals of Henan Province (Yuwei Yaozheng (2018) No 15) and the bargaining rules for special centralized purchase of anticancer drugs in Henan Province (Yuyao Lianban (2018) No 26), combined with the application of medical institutions and enterprise complaints, some online purchase problems of anticancer drugs are notified Imatinib tablets (0.1g) produced by Novartis Pharma produktions GmbH, Germany, Jiangsu Haosen Pharmaceutical Group Co., Ltd and Shiyao group Ouyi Pharmaceutical Co., Ltd were not confirmed in the price negotiation work of the special centralized purchase of anticancer drugs, and the whole group flow standard In order to ensure clinical medication, the imatinib tablets (0.1g) produced by the above three enterprises can be purchased and used by medical institutions You may have noticed in the announcement that imatinib tablets (0.1g) produced by Novartis, Jiangsu Haosen and Shiyao group are the whole group of flow standards in the province's special procurement, but medical institutions can still purchase and use them The reason is that at present, only Jiangsu Haosen and Shiyao group produce imatinib tablets (0.1g), while imatinib mesylate capsule is only produced by Zhengda Tianqing Therefore, even if the price of the two sides did not reach a consensus, but clinical medication can not be cut off, after all, patients can not afford to wait Based on this, Xiaobian checked the latest bidding price of imatinib tablets (0.1g * 1), i.e 1078.49 yuan, with Sichuan as the winning bidder and Ouyi Pharmaceutical Co., Ltd as the winning enterprise Compared with Novartis' highest bid price (12925 yuan), the bidding price decreased by 92% From the perspective of the national bid winning enterprises, only four enterprises, i.e kantle (Shanghai) pharmaceutical, Shiyao group, Jiangsu Haosen and Novartis pharmaceutical, have seized the beach Imatinib mesylate tablets (specification: 0.1g * 1) bid winning situation over the years 2018 imatinib mesylate tablets (specification: 0.1g * 1) bid winning situation of production enterprises 2018 imatinib mesylate tablets (specification: 0.1g * 1) bid winning situation of all parts of the country data source: Pharmaceutical intelligence data Statement: this opinion only represents the author, not the position of yaozhi.com, welcome to exchange and supplement in the message area; if you need to reprint, please be sure to indicate the author and source of the article.